TRT and fertility: what to know before your first shot
Testosterone replacement suppresses sperm production within weeks. Here is what the HPTA axis does on TRT, what recovery actually looks like, and which markers to track at each stage.
What to remember before reading on.
- 1TRT suppresses LH and FSH within weeks. Sperm production follows. Most men become functionally azoospermic within 10–24 weeks at full dose.
- 2Recovery is not guaranteed. Roughly 30–50% of long-term users do not return to their pre-TRT baseline once they stop.
- 3The same six-marker hormone panel works at every stage: pre-TRT baseline, on-TRT monitoring, and post-TRT recovery.
- 4If kids are anywhere on your roadmap, sperm cryopreservation before TRT is the only fully reversible safety net.
What TRT actually does to the male reproductive axis
The hypothalamus releases GnRH in pulses. The pituitary responds with LH and FSH. LH tells the Leydig cells in your testes to make testosterone. FSH supports the Sertoli cells, which run spermatogenesis. Testosterone in your blood tells the hypothalamus and pituitary to slow down. This is the HPTA — the hypothalamic-pituitary-testicular axis — and it is a closed feedback loop.
When you inject exogenous testosterone, the loop sees a lot of testosterone in the blood. It does what it is built to do: it tells the brain to stop signalling. Within weeks, GnRH drops. Within slightly longer, LH and FSH drop. Within roughly 10–24 weeks at full replacement doses, your testes — without their signal — stop producing sperm.
This is not a side effect. This is the mechanism. TRT works because it suppresses the axis.
What the data says about fertility on TRT
The clearest data comes from contraception trials, where exogenous testosterone (sometimes with progestins) was tested as a male contraceptive. Those trials are useful because they used full replacement doses and tracked outcomes carefully.
The headline numbers from those and related studies:
- LH and FSH drop to near zero within 4–8 weeks.
- Sperm count falls to azoospermia or near-azoospermia in roughly 10–24 weeks. In a large WHO contraception trial, ~98% of participants reached azoospermia or severe oligozoospermia within six months.
- Testicular volume decreases. This is reversible in most men, but visibly correlates with how suppressed the axis is.
- Recovery to baseline sperm parameters after stopping is typically 6 months at the median, with a long tail. Cohorts following long-term users find that 30–50% never return to pre-TRT baseline, particularly with longer cycles, higher doses, and older starting age.
If your roadmap includes children, treat these numbers as a planning constraint, not a footnote.
What to measure, when
The same six-marker hormone panel — Total + Free Testosterone, FSH, LH, SHBG, Prolactin, Estradiol — answers different questions at each stage.
Before TRT: build a real baseline
Most men start TRT on the back of a single low-T result, often drawn at the wrong time of day. That is not a baseline — it is a snapshot. A baseline is two morning samples, fasted, drawn before 10 am, ideally a few weeks apart. Any decision to start replacement should sit on that baseline, not on a single value.
You also want SHBG and the free fraction. A normal-looking total testosterone with high SHBG can leave free T inadequate; a borderline-low total with low SHBG can be functionally fine. The free number is what tissues see.
Finally, FSH and LH separate primary (testicular) from secondary (pituitary) hypogonadism. They change the right answer entirely. Low T with high LH is a testicular problem and TRT may make sense. Low T with low LH is a pituitary problem, and the right intervention may be GnRH or hCG-based, not exogenous testosterone.
On TRT: track the trade-off you accepted
Once on therapy, the question shifts. FSH and LH should be near zero — that confirms the axis is doing what it is supposed to do. SHBG and Estradiol drift with dose; these are the markers that quietly produce side effects (low libido despite normal-looking total T, water retention, gynaecomastia). Track once or twice a year and you catch drift early.
Periodic prolactin is cheap insurance. A subset of men on TRT develop subtle hyperprolactinaemia, and missing it means treating the result of an upstream problem.
Pause or stop: confirm recovery
If you ever pause TRT — for fertility, for a break, for any reason — the same panel becomes a recovery monitor. FSH and LH coming back is the first sign. Total testosterone follows. A semen analysis is the final step, ideally three months after the hormonal axis has clearly recovered, which gives one full spermatogenesis cycle.
Three panels three months apart, paired with a single semen analysis at the end, is sufficient for almost all men.
Cryopreservation before TRT is the only fully reversible safeguard
If kids are anywhere in your future, the cleanest insurance against the recovery lottery is to bank sperm before you start. Cost is typically modest compared to fertility treatment later. You can store for years with minimal annual fees.
This is the single decision that costs the least to take and the most to skip.
What to do today
If you are considering TRT, the order of operations is:
- Two morning hormone panels, two to four weeks apart, for a real baseline.
- A discussion with a clinician who reads the panel — not just your total testosterone — and is willing to consider whether your low T is testicular or pituitary in origin.
- If TRT is the right answer for your specific case: cryopreservation first, then the script.
If you are already on TRT without a baseline, the next-best move is a current panel. It confirms suppression, tracks SHBG and Estradiol drift, and gives you the comparison point for any future pause or pivot.
A panel is data you keep for the rest of your life.
Sources cited: Hayes & Hodson 2017 (azoospermia in TRT trials), Liu et al. 2006 (median recovery time) — full entries on /science.